Advertisement

Topics

Swiss Biotech and Japanese Pharma Team Up to Tackle Neurodegenerative Disease

04:53 EST 9 Nov 2017 | Labiotech.eu

Neurimmune and Ono Pharmaceutical have partnered to develop an antibody drug against a still undisclosed neurodegenerative disease.  Neurimmune has a new partner to help it develop treatments for neurodegenerative diseases. Ono Pharmaceutical will work together with the Swiss biotech to develop human ...

This awesome article Swiss Biotech and Japanese Pharma Team Up to Tackle Neurodegenerative Disease appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: Swiss Biotech and Japanese Pharma Team Up to Tackle Neurodegenerative Disease

NEXT ARTICLE

More From BioPortfolio on "Swiss Biotech and Japanese Pharma Team Up to Tackle Neurodegenerative Disease"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...